Clinical Trial Update: Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rhPSMA-7.3 PET/CT imaging in men with high-risk prostate cancer after conventional imaging. The study assesses whether imaging results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: MidLantic Urology | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING